Search Results for keywords:"PCI Pharma Services"

Found 2 results

Search Results: keywords:"PCI Pharma Services"

💰 Only
Oldest Newest
  • 2025-05118 — Foreign-Trade Zone (FTZ) 35; Authorization of Production Activity; PCI Pharma Services; (Pharmaceutical Products); Croydon and Philadelphia, Pennsylvania
    Type:Notice
    Citation:90 FR 13731
    Reading Time:less than a minute

    PCI Pharma Services submitted a notification on November 21, 2024, to the Foreign-Trade Zones (FTZ) Board about proposed production activities at their facilities in Croydon and Philadelphia, Pennsylvania. The notification followed FTZ Board regulations, and public comments were invited through a notice in the Federal Register on November 29, 2024. By March 21, 2025, the FTZ Board decided that no further review was needed, and authorized the production activity as per the FTZ Act and regulations.

    Simple Explanation

    PCI Pharma Services, a company in Pennsylvania, got permission to make medicines in special areas called Foreign-Trade Zones, which helps them do this more easily and cheaply. The permission was given after making sure everything was okay and letting people share their thoughts.

  • 2025-05115 — Foreign-Trade Zone (FTZ) 35; Authorization of Production Activity; PCI Pharma Services; (Pharmaceutical Products); Croydon and Philadelphia, Pennsylvania
    Type:Notice
    Citation:90 FR 13732
    Reading Time:less than a minute

    PCI Pharma Services submitted a proposal to the Foreign-Trade Zones (FTZ) Board on November 21, 2024, to begin production activities at their facilities in Croydon and Philadelphia, Pennsylvania, within FTZ Subzone 35L. This notification adhered to the FTZ Board's regulations, and the public had the opportunity to comment on it as announced in the Federal Register on November 29, 2024. On March 21, 2025, the FTZ Board decided that no further review was needed, authorizing the proposed production activities in accordance with FTZ regulations.

    Simple Explanation

    PCI Pharma Services wants to make medicines in two places in Pennsylvania, and a special group that helps with trade said it's okay for them to start doing this.